Abstract
A major obstacle in gene delivery is the transport of intact plasmid DNA (pDNA) to target sites. We sought to investigate the kinetic processes underlying the degradation of pDNA in a rat plasma model, as this is one of the main components responsible for the clearance of pDNA after intravenous administration. We further sought to construct a complete kinetic model to describe the degradation of all three topoforms (supercoiled, open circular, and linear) of pDNA in a rat plasma model. Supercoiled pDNA was incubated in isolated rat plasma at 37°C in vitro. At various time points, the plasma was assayed by electrophoresis for the amounts of supercoiled, open circular, and full-length linear pDNA remaining. The calculated amounts remaining were fit to linear differential equations describing this process. In this model, pDNA degradation is considered to be a unidirectional process, with supercoiled degrading to open circular and then to the linear topoform. The calculated kinetic parameters suggested that supercoiled pDNA degrades in rat plasma with a half-life of 1.2 minutes, open circular pDNA degrades with a half-life of 21 minutes, and linear pDNA degrades with a half-life of 11 minutes. Complexation of pDNA with liposomes resulted in a portion of the supercoiled plasmid remaining detectable through 5.5 hours.
Similar content being viewed by others
References
Hirose S, Ohaba R. Supercoiling facilitates the assembly of active chromatin. In: Andoh T, Ikeda H, Oguro M. eds. Molecular Biology of DNA Topoisomerases. Boca Raton, FL. CRC Press; 1993;87–93.
Niven R, Pearlman R, Wedking T, Mackeigan J, Noker P, Simpson-Herren L, Smith JG. Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice. J Pharm Sci. 1998;87:1292–1299.
Gosse CH, Le Pecq JB, Defrance P, Padetti C. Initial degradation of deoxyribonucleic acid after injection in mammals. Cancer, Res. 1965;25:877.
Osaka G, Kendall C, Cuthbertson A, Godowski P, Patapoff T, Ryan A, Gadek T, Mordenti J. Pharmacokinetics tissue distribution, and expression efficiency of plasmid [33P] DNA following intravenous administration of DNA/cationic lipid complexes in mice: Use of a novel radionucleolide approach. J Pharm Sci. 1996;85:612–618
Thierry AR, Rabinovich R, Peng B, Mahan LC, Bryant JL, Gallo RC. Characterization of liposome-mediated gene delivery: Expression, stability, and pharmaco kinetics of plasmid DNA. Gene Therapy. 1997;4:226–237.
Kawabata K, Takakaura Y, Hashida M. The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm Res. 1995;12:825–830.
Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10:1093–1095.
Cantor CR, Schimmel PR. Biophysical Chemistry Part III: The Behavior of Biological Macromolecules. New York. W.H. Freeman: 1980
Chused TM, Steinberg AD, Talal N. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exper Immunol. 1972;12:465–476.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: August 13, 1999.
Rights and permissions
About this article
Cite this article
Houk, B.E., Hochhaus, G. & Hughes, J.A. Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS PharmSci 1, 9 (1999). https://doi.org/10.1208/ps010309
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/ps010309